Chargement en cours...
Critical appraisal of eculizumab for atypical hemolytic uremic syndrome
The biology of atypical hemolytic uremic syndrome has been shown to involve inability to limit activation of the alternative complement pathway, with subsequent damage to systemic endothelial beds and the vasculature, resulting in the prototypic findings of a thrombotic microangiopathy. Central to t...
Enregistré dans:
| Publié dans: | J Blood Med |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4835139/ https://ncbi.nlm.nih.gov/pubmed/27110144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S36249 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|